89th General Assembly · Funnel one-pager · Monday, November 9, 2026
SF 2117: Relating to experimental treatments for terminally ill persons, and including effective date provisions
Died when the session ended · The General Assembly adjourned on May 24, 2022. Bills that didn’t pass both chambers died.
What it does
This bill relates to experimental treatments for terminally ill persons. The bill expands the definition of “eligible patient” to include a person who is receiving mechanical ventilation to prolong life. The bill also expands the definition of an “investigational drug, biological product, or device” to include the off-label use of a drug as defined in the bill. The bill replaces the current required involvement of the patient’s physician or the patient’s treating physician to instead require involvement from a physician or a treating physician to fulfill certain duties. The bill takes effect upon enactment.
Sponsors
Not listed
Cost
No fiscal note
Senate subcommittee · named January 31, 2022
- Sen. Jeff Edler (R)
- Sen. Joe Bolkcom (D)
- Sen. Mark Costello (R) · mark.costello@legis.iowa.gov
Lobbying · 3 for, 3 against
For: Informed Choice Iowa; Iowans for Medical Marijuana; VALOR Iowa
Against: Iowa Hospital Association; Iowa Independent Physician Group; The Iowa Clinic, P.C.
In plain words
- January 26, 2022Filed in the Senate and sent to the Human Resources committee
- January 31, 2022Senate subcommittee named: Edler, Bolkcom and Costello
- February 2, 2022Subcommittee recommended passing it with changes
From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/89/SF2117